Internal Server Error

Axys Pharmaceuticals - About the company

Axys Pharmaceuticals is an acquired company based in San Francisco (United States), founded in 1998. It operates as a Protease-based drugs for cancer and autoimmune diseases. Axys Pharmaceuticals has raised an undisclosed amount in funding.

Company Details

Axys Pharmaceuticals (formerly called Arris) was focussed on developing small molecule drugs for cancer and autoimmune disorders. It had partnered its R&D programs with Merck, Aventis and Bayer AG to develop drugs for osteoporosis, asthma, inflammatory and autoimmune diseases, and cardiovascular disease. Its primary drug discovery research has been directed at proteases-proteins that initiate key biological processes throughout the body and claims to have applied a structure-based drug design technology platform for the identification and optimization of clinical candidates. In 2001, Celera acquired Axys.
Key Metrics
Founded Year
1998
Location
San Francisco, United States
Stage
Acquired
Exit Details
Acquired by Celera (Jun 13, 2001)

Axys Pharmaceuticals's acquisition details

Axys Pharmaceuticals got acquired by Celera on Jun 13, 2001 at an acquisition amount of $*****.
Click here to take a look at Axys Pharmaceuticals's acquisition in detail
Sign up to download Axys Pharmaceuticals' company profile

Axys Pharmaceuticals's funding and investors

Axys Pharmaceuticals has raised funding over 2 rounds. Its first funding round was on Oct 01, 1998. Axys Pharmaceuticals has 4 institutional investors.

Here is the list of recent funding rounds of Axys Pharmaceuticals:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Aug 31, 2000
5621001
Grant (prize money)
4346598
6322159
7775833
6962781
Oct 01, 1998
4974743
Grant (prize money)
9240859
4891088
9727592
lockAccess funding benchmarks and valuations. Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Axys Pharmaceuticals's Investments and acquisitions

Axys Pharmaceuticals has made no investments or acquisitions yet.

Reports related to Axys Pharmaceuticals

Here is the latest report on Axys Pharmaceuticals's sector:

News related to Axys Pharmaceuticals

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Axys Pharmaceuticals

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford